COMMUNIQUÉS West-GlobeNewswire

Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET
28/04/2026
HOLLISTON, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2026, before the market opens on May 12, 2026, and will [...]
Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results
28/04/2026
SOMERSET, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, May 12 [...]
Leadership Team Expansion to Support the Need for Healthier Employees
28/04/2026
TORONTO, April 28, 2026 (GLOBE NEWSWIRE) -- Employers of all sizes are confronting unprecedented economic and geopolitical pressures that are resulting in crisis levels of employee burnout and mental health challenges. [...]
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
28/04/2026
SEATTLE, April 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended [...]
Reacta Healthcare Announces Expansion into Asia-Pacific and Appoints Professor Gary Wing-Kin Wong to Advisory Board
28/04/2026
DEESIDE, United Kingdom, April 28, 2026 (GLOBE NEWSWIRE) -- Reacta Healthcare, a leading developer and manufacturer of pharmaceutical-grade oral food challenge (OFC) products for food allergy diagnostics, today [...]
Transactions in connection with share buy-back program
28/04/2026
Company announcement no. 12 - 26 28 April 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Theolytics Announces First Patient Dosed in the OCTOPOD-IP Trial, a US Phase 1 Trial with THEO-260, a Novel Oncolytic Immunotherapy Targeting Ovarian Cancer
28/04/2026
OCTOPOD-IP is being conducted to investigate intraperitoneal (IP) administration of THEO-260 in women with advanced platinum-resistant ovarian cancer Recruitment on track in OCTOPOD-IV, a Phase 1/2a multi-centre, multi- [...]
Clariane annonce l’offre de 230 millions d’euros d’obligations senior additionnelles en vue de refinancer ses obligations hybrides vertes perpetuelles
28/04/2026
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, AU JAPON OU EN AUSTRALIE, OU DANS TOUTE AUTRE JURIDICTION OU IL EST ILLÉGAL DE DIFFUSER, DE PUBLIER OU DE [...]
Clariane has launched a proposed offering of €230 million of additional senior notes to refinance its hybrid green perpetual bonds
28/04/2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Clariane has [...]
Dr. Petros Kotsidis: KFSH Positions AI as a Scalable Model for Real-World Healthcare Innovation
28/04/2026
SUNNYVALE, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Dr. Petros Kotsidis, Chief Digital Officer at King Faisal Specialist Hospital & Research Centre (KFSH), said the hospital is adopting a system-level approach to [...]
Dr. Björn Zoëga: Scaling Integrated Digital Systems Will Define the Future of Healthcare
28/04/2026
SUNNYVALE, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Dr. Björn Zoëga, CEO of King Faisal Specialist Hospital & Research Centre Riyadh (KFSH), said the future of healthcare will be defined not by innovation itself, [...]
Holivita Launches a New Platform, Offering a Human-Centric Blueprint for Health Through AI and Your DNA
28/04/2026
DUBAI, United Arab Emirates, April 28, 2026 (GLOBE NEWSWIRE) -- Holivita , a forward-thinking med-tech company, announces the launch of its platform designed to support everyday health and self-care. “Health should no [...]
KFSH Awards Innovation Challenge Winners at C3 Davos of Healthcare™ Silicon Valley Summit
28/04/2026
SUNNYVALE, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH), a Global Strategic Partner at the C3 Davos of Healthcare™ Silicon Valley Summit, awarded the winners of [...]
Yinuo Chen, founder of three major Fertility centers—Tulip, ONELIFE, and Sino—was invited to participate in the Shanghai Medical Exhibition
28/04/2026
BISHKEK, Kyrgyzstan, April 28, 2026 (GLOBE NEWSWIRE) -- Yinuo Chen, founder of three major fertility centers—Kyrgyzstan Tulip, Thailand ONELIFE, and Georgia Sino—was invited to participate in the 2026 Shanghai [...]
Novartis delivered strong growth in priority brands and launches in Q1; FY 2026 guidance reaffirmed
28/04/2026
Ad hoc announcement pursuant to Art. 53 LR First quarter Net sales declined -5% (cc 1 , -1% USD), as growth drivers were more than offset by US generic erosion Continued strong performance from priority brands including [...]
Castle Rock Hormone Health Announces National Franchise Launch with Franchise Sidekick Amid Growing Demand for Longevity Medicine
28/04/2026
Castle Rock Hormone Health launches a national franchise program with Franchise Sidekick, targeting 100–250 new clinics in 2026 to meet rising demand for longevity-focused, cash-pay hormone and preventive health [...]
CORE Soft Tissue Therapy Reports Full Booking Capacity in First Year as Referral Growth Supports South London Expansion
28/04/2026
Photo courtesy of CORE Soft Tissue Therapy LONDON, April 28, 2026 (GLOBE NEWSWIRE) -- CORE Soft Tissue Therapy reports that its East Dulwich clinic reached full booking capacity within its first year of operation, with [...]
Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025
28/04/2026
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 28, 2026, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end of this news release AGAMREE® delivers strong growth as global [...]
Idorsia reports strong Q1 2026 performance with 74% QUVIVIQ sales growth year-on-year
28/04/2026
Ad hoc announcement pursuant to Art. 53 LR Preparation is underway to publish the strong pediatric daridorexant data and engage with regulatory authorities on next steps Co-promotion of QUVIVIQ is being expanded across [...]

Pages